Epidemiologic data indicates that blacks may be more susceptible than whites to infection by Mycobacterium tuberculosis. Resistance to the in vivo growth of Mycobacteria in mice correlates with the persistence of MHC class II expression by peritoneal macrophages. The expression of HLA-DR by human monocytes from different groups of individuals also differs. The increase in the expression of HLA-DR by monocytes that occurs upon in vitro culture was prevented by the protein synthesis inhibitor cycloheximide (CHX) in a majority of black donors. In contrast, the increase in HLA-DR expression by monocytes from the majority of white donors was unaffected.
INTRODUCTION
The expression of HLA class II glycoproteins by antigenpresenting cells is necessary for the induction and regulation of the immune response [1] . The class II glycoproteins, HLA-DR, HLA-DP and HLA-DQ are expressed by human peripheral blood monocytes. More than 50% of freshly isolated peripheral blood monocytes express HLA-DR. In contrast the expression of HLA-DP or HLA-DQ by the same cell population is much lower. Short term in vitro culture of human monocytes results in a transient increase in both the percentage of cells expressing each of the class II proteins as well as an increase in their fluorescence intensity [2] [3] [4] . The factors responsible for the transient increase in HLA class II expression have not yet been defined. Some studies have shown that the addition of antibody to interferon-gamma (IFN-y) prevents the increase in HLA expression while others have shown that the increase is independent of the presence of cytokine [5] [6] [7] .
MHC class II glycoproteins can be expressed transiently or persistently by murine peritoneal macrophages [8, 9] . The differences in how I-A is expressed and resistance to Mycobacterial growth are closely linked and map to the same region on mouse chromosome 1. A syntenic group of genes has been shown to map to human chromosome 2q [10, 1 1] . Macrophages from mice that are resistant to the in vivo growth of Mycobacterium bovis (strain bacille Calmette-Guerin (BCG)) can be induced to persistently express I-A glycoproteins while macrophages from mice that are susceptible to BCG will only transiently express Correspondence 163 I-A. An important characteristic of I-A that is persistently expressed is that the synthesis of new I-A protein is not required [9, 12, 13] . Incubation of macrophages from BCG-resistant mice with cycloheximide (CHX) does not affect the expression of I-A that is persistently expressed. In contrast, incubation of macrophages from BCG-susceptible mice with CHX results in a decrease in the percentage of cells expressing I-A. Similarly, when human monocytes from patients infected with Mycobacterium tuberculosis were incubated with puromycin, the expression of HLA-DR by the cells was suppressed [5] .
Recent reports have suggested that individuals may differ with regard to their innate resistance to Mycobacterial disease [14] [15] [16] [17] . Stead and colleagues studied the incidence of tuberculosis among the residents in racially integrated nursing homes [16] . The authors concluded from the epidemiologic data that black residents were twice as likely to become newly infected than were similarly exposed white residents. Similarly, Crowle & Elkins [17] reported that the replication rate of M. tuberculosis in monocytes from black donors was greater than the replication rate of the micro-organism in monocytes from white donors. Based on these reports and on our observations that difference in the persistence of MHC class II glycoprotein expression correlates with resistance to the in vivo growth of Mycobacteria in mice, we compared the expression of HLA-DR by monocytes from black and white donors. The results of this investigation show that HLA-DR expression by monocytes from white donors and by monocytes from some of the black donors is different. Thus, while CHX did not affect the spontaneous increase of HLA-DR by monocytes from white donors, CHX prevented the increase in HLA-DR expression by monocytes from some of the black donors. The possible implications of 100 r these observations to susceptibility to Mycobacterial infection are discussed.
MATERIALS AND METHODS

Reagents
Four hybridomas, producing monoclonal antibodies to HLA-DR, clone L243 (ATCC no. HB55), HLA-DQ, clone Genox 3.53 (ATCC no. HB103), human IFN-y clone IFGCP-FIBAIO (ATCC no. HB8291), as well as clone 63D3 (ATCC no. HB44) producing antibody to the monocyte marker Mo2 were obtained from the American Type Culture Collection and grown in our laboratory. Antibodies were purified by Protein A chromatography. A MoAb reactive with HLA-DP was purchased from Becton Dickinson (Mountain View, CA). All anti-HLA antibodies were conjugated to FITC by the method described by Wofsy et al. [ 18] and were adjusted to conform with commercial clinical reagents purchased from Becton Dickinson. Anti-Leu-M5, which reacts with CDI Ic, was obtained from Becton Dickinson. Both Leu-M5 and anti-63D3 were used as monocyte markers and were biotinylated according to the method of Bayer & Wilchek [19] . Strepavidin-phycoerythrin was purchased from Tago (Burlingame, CA). Anti-cytokine antibodies reacting with human IFN-fl, tumour necrosis factoralpha (TNF-a) and IFN-oa were purchased from Boehringer-Mannheim (Indianapolis, IN). Antibodies reacting with M-CSF and GM-CSF were purchased from Genzyme (Boston, MA). CHX was purchased from Sigma (St Louis, MO).
Isolation ofperipheral blood monocytes Sixty millilitres of blood were drawn by venipuncture from consenting donors into 1 ml of 5% EDTA in phosphatebuffered saline (PBS) as anti-coagulant and the mononuclear cells isolated by Ficoll-Hypaque density gradient (Pharmacia, Piscataway, NJ). Male donors were between the ages of 20 and 50 years without a recent history of illness or of receiving medication. The mononuclear cells were washed in Hank's balanced salt solution containing 0-1 % (w/v) bovine serum albumin (HBSS-BSA) and resuspended in 10 ml of HBSS-BSA. Monocytes were isolated by counterflow centrifugation [20] . The purity of the monocytes, as assessed by differential staining and staining for non-specific esterase as well as by identification with anti-Leu-M5 or anti-63D3, was routinely 85-95%.
Culture of monocytes and determination of HLA expression
Monocytes were suspended in Iscove's modified Dulbecco's medium (Whittaker Bioproducts, Walkersville, MD) supplemented with 10 mm glutamine, 100 U/ml penicillin, 100 ug/ml streptomycin, 10-4 M 2-mercaptoethanol and 20% fresh, pooled human serum at a concentration of 5 x 106 cells/ml. The serum was not heat inactivated and was stored for up to 30 days at 4°C. The cell suspension (I ml) was added to Teflon vials (Cole Palmer, Chicago, IL) and cultured in 5% CO2. The viability of the monocytes after culture was always greater than 95 %. When determining the effect of in vitro culture and of CHX the experiments using monocytes from the same donor were done in parallel.
Monocytes were assayed for HLA class II expression by immunofluorescence and flow cytometry. Briefly, 5 x 105 cells were aliquoted into microfuge tubes and fixed by treatment with 1% paraformaldehyde for 30 min at 4°C. Cells were washed and then treated with a solution of IgG2a or IgG2b (4 mg/ml) of unrelated mouse MoAbs in order to block Fc receptors. Cells were then washed and treated with a combination of 0 4 pg biotinylated anti-Leu-M5 or anti-63D3 MoAb and 0 4 pg of either FITC-conjugated HLA-DR, HLA-DP or HLA-DQ for 45 min at 4°C. After washing the cells were treated with I pg of Strepavidin-phycoerythrin for 45 min at 4°C. The cells were then washed, resuspended in 0 5 ml PBS and analysed for fluorescence using a Coulter Epics Elite flow cytometer (Coulter, Hialeah, FL). Monocytes were identified by forward and 90°light scatter and by reactivity with the Leu-M5 or 63D3 reagents. All cells staining with PE were analysed for reactivity with anti-HLA class II reagents. The per cent of cells expressing HLA class II molecules as well as their fluorescence intensity were recorded.
Statistical analysis
For each analysis we used a two-sampled t-test. The dependent variable in our statistical analysis was the difference between the measured levels of HLA-DR at day 1 without CHX or between day 1 with CHX and day 0. For each of our analyses, an examination of residual plots did not contradict the appropriateness of the methods used.
RESULTS
Quantification of initial HLA class II expression
Dual parameter flow cytometric analysis was used to quantify the surface expression of HLA-DR, HLA-DP and HLA-DQ on monocytes. The data obtained from each individual donor are summarized in Fig. 1 as dot plots of the percentage of cells expressing HLA class II or the mean peak fluorescence of the population. On average, 56% of freshly isolated monocytes from the white donor population and 66% of the monocytes from the black population expressed HLA-DR. There was no statistically significant difference among the groups of donors. Similarly, the populations expressed comparable levels of HLA-DP (20-25%) and HLA-DQ (25%). 
Effect of in vitro culture of HLA class expression
In vitro culture of monocytes results in a spontaneous increase in HLA class II expression [2] [3] [4] [5] . When we compared the change that occurred in the expression of HLA-DR we found that the increase in the expression of HLA-DR was similar among the donor groups. The data in Fig. 2 are dot plots of the change in the percentage of cells expressing HLA class II after 24 h of in vitro culture minus the percentage of cells expressing HLA class II initially. Thus, the dots appearing above the zero line indicate that the percentage of cells from a given donor increased during overnight incubation. Similarly, dots appearing below the line indicate that the percentage of cells expressing HLA class II, from that individual donor, decreased after overnight culture. When we compared the change that occurred in the expression of HLA-DR we found that the expression of HLA-DR increased an average of 15-25% among both of the donor groups. The expression of HLA-DQ and HLA-DP also increased (data not shown). There were no statistical differences among the donor populations. The time course of the increase, which was maximal within 4 h, was identical among the donor populations ( Fig. 3) .
In order to eliminate the possibility that the spontaneous increase in HLA class II expression was due to the production of IFN-y by the small percentage ofcontaminating lymphocytes [3] we incubated the monocyte cultures with a dilution of MoAb that neutralized 500 U of recombinant human IFN-y (rhIFN-y). The results in Table I show that the spontaneous increase in HLA-DR expression by monocytes from black or white donors Peripheral blood monocytes were isolated by elutriation and analysed for expression of HLA-DR immediately and after 24 h of in vitro culture in the presence or absence of a dilution of a MoAb that neutralized 500 U of rhIFN-y. 
The effect of cycloheximide on HLA-DR expression
In order to determine if the spontaneous increase in HLA-DR expression required the synthesis of new protein, we incubated cultures of monocytes from each of the donor populations with 25 jg/ml of CHX. We found that CHX prevented the spontaneous increase of HLA-DR in 71% of the individuals when the monocytes were obtained from black donors (Fig. 4) . In contrast, CHX prevented the increase in HLA-DR expression by the monocytes from only 30% of the white donors. The difference in the changes between the groups that resulted from CHX treatment was significant (P<0001). Thus, while the percentage of cells from the white donors expressing HLA-DR increased by 19%, the expression of HLA-DR by monocytes from black donors decreased by 18% in the presence of CHX. Despite the decrease in the percentage of cells expressing HLA-DR, the fluorescence intensity of the monocytes that continued to express HLA-DR increased. There were no differences in the changes in intensity between the two donor populations. It was possible that the decrease that resulted from cultivation of black donor monocytes with CHX represented an occasional occurrence rather than real differences between the populations. In order to determine the reproducibility of our observations we selected several black donors and several white donors for multiple testing. The results (Table 2) show that in Peripheral blood monocytes were isolated from each donor over a 6-8 week period. The cells were cultured in Teflon vials at 5 x 106/ml in the presence of cycloheximide (CHX) . The data are the changes in per cent of cells expressing HLA-DR that occurred in the presence of CHX minus the per cent of cells expressing HLA-DR initially.
each of three trials the change in the percentage of cells expressing HLA-DR in the presence of CHX was reproducible regardless of whether the monocytes were obtained from white or black donors (donors 1-3, black; donor 5, white). Similarly, the increase in HLA-DR expression was also reproducible (donor 4, white).
DISCUSSION
The results of this study indicate that human monocytes can be separated into two groups depending on the effects of CHX on the expression of HLA-DR. The culture of monocytes, from one group of individuals, in the presence of CHX resulted in a decrease in the expression of HLA-DR. The expression of HLA-DR by monocytes from the second group was not affected by the presence of CHX in the culture medium. The mechanism that accounts for the differences in expression are not yet known. CHX inhibits the synthesis of new protein. Thus the increase in HLA-DR expression that occurs in the white donor monocytes and in some of the black donor monocytes does not require the synthesis of new HLA class II protein. Instead, our results suggest that the increase in HLA-DR is the result of the cycling of a previously synthesized intracellular pool of class II glycoprotein to the cell surface.
In contrast, when monocytes from the majority of the black donors were cultured in the presence of CHX, a decrease in HLA-DR expression was observed. In the absence of the synthesis of new protein the level of expression of HLA-DR decreased. This decrease was not observed to occur with monocytes from all black donors, however. The differences in the response of the donor monocytes to culture with CHX suggest that the decrease in HLA-DR expression is due to the inability to replace that which was lost from the cell surface. Thus, the inhibition of protein synthesis prevented the replacement of surface HLA-DR. Our results further suggest that there may be differences in the intracellular pool of HLA class II in monocytes from the two donor groups. Our results support observations made by others that show that a spontaneous increase in the expression of HLA class II glycoproteins occurs during in vitro culture [2] [3] [4] [5] . The mechanism that results in the spontaneous increase is not known. Some reports indicate that the increase is due to the production of IFN-y by cells that are contaminating the monocyte preparations [3] . When we added antibody to human rhIFN-y, in an amount sufficient to neutralize 500 U, however, no inhibition of the increase in expression of HLA-DR was observed. Similarly, the increase in HLA-DR expression does not appear to be affected by the addition of rhIFN-y to the cultures. The presence of IFN serves to maintain the level of HLA class II expression over an extended period of time [21] . In preliminary studies we have found that antibody to the beta chain of LFA-I prevents the increase in HLA-DR expression. This suggests that the increase may be the result of receptor-ligand interaction.
The lack of effect of CHX on the increase in HLA-DR expression by monocytes from most of the donors is similar to that reported by Smith & Ault [4] and Tweady et al. [5] who showed that the inclusion of CHX or puromycin in cultures of monocytes resulted in an increase in HLA-DR. The increase that occurs in the presence of CHX, in both our studies, was slightly less than that which occurs in its absence. Together, these observations indicate that only a small fraction of the increase in HLA-DR may be due to the synthesis of new protein.
Culture ofmonocytes for as little as 1 h resulted in an increase in HLA-DR expression which reached a maximum by about 4 h. The time course for the increase is similar to that reported by others [2] [3] [4] [5] and was identical for monocytes from both donor groups. When an individual's monocytes were retested for their response to CHX, we found that co-cultivation with CHX always resulted in a decrease in the expression of HLA-DR. This observation suggests that the decrease in HLA-DR expression is the result of differences in the regulation of class II within the different donor groups and further that this is due to inherited differences.
The stability of HLA class II expression by monocytes from one group of human donors is similar to that which we have reported for mouse macrophages [8, 9, 12, 13] . Thus, MHC class II expression by murine peritoneal macrophages can be induced to be stably expressed. The stable expression of I-A in mice correlates with resistance to the in vivo growth of Mycobacteria. It is of particular interest, therefore, that several recent reports indicate that differences among groups of individuals may also occur with regard to their susceptibility to tuberculosis [14] [15] [16] [17] . The differences we have observed in the expression of HLA-DR are similar to the differences in I-A expression that we observe in populations of mice that are resistant or susceptible to Mycobacterial growth and appear to be controlled by Bcg [9] . Similarly, the differences in HLA-DR expression in man may also be related to differences among the populations in susceptibility to tuberculosis. It is particularly interesting to note that the expression of HLA-DR by monocytes from patients with tuberculosis decreases when the monocytes were incubated with drugs that inhibit protein synthesis [5] . We do not yet understand the mechanism that accounts for the differences in MHC class II glycoprotein expression that we have observed in mice and man, nor its relationship to Mycobacterial resistance. Bcg has been shown to control the growth of several Mycobacterial species including Mycobacterium bovis (strain BCG) [22] , M. avium-intracellulare [23] and M. kepraemurium [24] as well as Leishmania donovani (Lsh) [25] and Salmonella typhimurim (Ity) [26] . While Bcg controls the growth of these organisms following i.v. injection it is not clear if the gene is active following lung infection [27] [28] [29] . The gene that controls resistance to Mycobacterial growth in mice maps to chromosome 1 and is syntenic with a group of genes on chromosome 2q in man [10, 11] . While it is not clear if Bcg can control the growth of M. tuberculosis in mice [29] , it would be of interest to determine the relationship of our observations to those reported by Sher et al. [10] using a probe for villin that is closely linked to Bcg in mice. Thus, villin could be used to detect restriction fragment length polymorphism (RFLP) differences among individuals within families with a high incidence of tuberculosis [11] . The relationship of differences in HLA-DR expression to resistance to Mycobacterial disease will not be established unless similar studies within these families can also be done.
